Skip to main content
Signal8

LifeMD expands access to Lilly’s self-pay GLP-1 medicines, enabling option to dispense and ship directly to patients nationwide

$LFMDPress releaseNov 5, 2026, 7:30 AM ET

LifeMD announced an arrangement with Eli Lilly enabling its affiliated pharmacy to directly dispense and ship Lilly's self-pay GLP-1 medicines, Zepbound and Foundayo, to eligible patients nationwide. Prescriptions from LifeMD-affiliated providers are fulfilled by LifeMD's licensed mail-order pharmacy at Lilly's established self-pay cash price, with no insurance billing.

Key figures

Geographic coverage
nationwide (50 states)
Medications included
["Zepbound (tirzepatide)","Foundayo (orforglipron)"]

AI analysis

Red flags2 · Pro

The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.

    LFMD: LifeMD expands access to Lilly’s self-pay GLP-1 medicines, enabling option to dispense and ship directly to patients nationwide — AI Analysis | Signal8